Singular Genomics Systems, Inc. (OMIC) Stock Split, History Data
Working capital analysis
In terms of working capital, Singular Genomics Systems, Inc. maintains a healthy position.
The total current assets of the company are valued at $192228000.
This represents a growth rate of -28.389% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $16233000, exhibiting a growth rate of -78.142% year-on-year.
The receivables, another significant portion of the current assets, are valued at $1584000.
The year-on-year growth rate for receivables is 73.494%.
The inventory, which forms a critical part of the assets, is valued at $13572000.
This represents a healthy year-on-year growth of -25.515%
On the liabilities side, the company's current liabilities total $18287000.
This reflects a growth rate of 29.530% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
Cash and investments
16.23
74.27
201.05
11.69
5.50
Receavebles
1.58
0.91
1.05
0.02
0.00
Inventory
13.57
18.22
3.01
0.02
0.00
Other
1.46
4.72
4.48
0.65
0.26
Total Current Assets
192.23
268.43
347.76
27.57
46.46
Acc Payable
2.59
3.10
2.35
0.43
0.56
Short Term Debt
7.76
6.32
0.00
0.93
0.00
Other Current Liab
1.86
4.70
4.40
0.74
0.55
Current Liabilities
18.29
14.12
6.74
3.69
1.11
Capital Structure
When examining the capital structure of Singular Genomics Systems, Inc., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Singular Genomics Systems, Inc. has chosen to reinvest in the business rather than distribute as dividends.
